Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare the pharmacokinetics and safety/tolerability between NVP-1805-R1 and NVP-1805-R2
pharmacokinetics and safety/tolerability between NVP-1805-R1 and NVP-1805-R2
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NVP-1805-R1 | Experimental | Drug: NVP-1805-R1 1 tablet, oral dosing |
|
| NVP-1805-R2 | Experimental | Drug: NVP-1805-R2 1 tablet, oral dosing |
|
| NVP-1805-R1 and NVP-1805-R2 | Experimental | Drug: NVP-1801-R1 1 tablet and NVP-1801-R2 1 tablet co-administration(oral dosing) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NVP-1805-R1 | Drug | 1 tablet, multiple oral dosing |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Pharmacokinetic interaction | Area under the curve (AUC) | 0hours - 48hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dong Sung Shin, M.D. | Gachon University Gil Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Navipharm | Suwon | Gyeonggi-do | 16209 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33326064 | Derived | Kim CH, Kang SI, Shin D. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects. Adv Ther. 2021 Feb;38(2):1094-1105. doi: 10.1007/s12325-020-01592-8. Epub 2020 Dec 16. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| NVP-1805-R2 | Drug | 1 tablet, multiple oral dosing |
|
|
| NVP-1805-R1 and NVP-1805-R2 | Drug | NVP-1805-R1,1 tablet and NVP-1805-R2, 1 tablet, co-administration, multiple oral dosing |
|
|